Michelson Prizes

April 12, 2023

The Michelson Prizes: Next Generation Grants are annual awards of $150,000which support early-career investigators who are working to significantly advance human immunology and vaccine and immunotherapy research for major global diseases.  The Prizes are awarded by the Michelson Medical Research Foundation and the Human Immunome Project (previously the Human Vaccines Project) —  applications are being accepted from 3 April 3 till 11 June 2023. Additional info can be found here.

  • About the Prizes: We are looking for research aimed at tackling the current roadblocks that exist in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. 
  • Eligibility: Researchers / scientists who are 35 and under.
  • Disciplines: Applicants from the full spectrum of immunology-related disciplines, including clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, environmental health, nanotechnology, etc., are encouraged to apply.  
  • Deadline:  11 June 2023

More News

Call for participation in the World Data System survey

February 18, 2025

Opportunity: The Club of Rome Communications Fellowship

February 18, 2025

Call for abstracts for the World forum for women in science 2025-Jordan

February 18, 2025

New IUIS Gender Equity Committee Review Article is Published: Global perspectives to enhance strategies for advancing women in healthcare and STEMM leadership

February 10, 2025Gender Equity Committee (GEC)

Teaching Sustainable Development Goals: Methods for Education

February 7, 2025

Teaching Sustainable Development Goals: Methods for Education

January 15, 2025

Funding Opportunities: In Vitro Bioassay Systems Modeling Dysfunction in Neurodegenerative Diseases

January 15, 2025

IVVN ECR Career Development Fellowship Scheme

January 6, 2025

IUIS Executive Committee Statement on Membership Dues

December 20, 2024